Appendix B. Sources of evidence considered by the Committee

Appendix B. Sources of evidence considered by the Committee

The following documentation and opinions were made available to the Committee:

A The assessment report for this appraisal was prepared by West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, The University of Birmingham:

I I Dretzke J, Sandercock J, Bayliss S, et al. The clinical effectiveness and cost effectiveness of pre-hospital intravenous fluids in trauma patients, July 2003

B The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, Assessment Report and the Appraisal Consultation Document (ACD). Consultee organisations are provided with the opportunity to appeal against the Final Appraisal Determination:

I Manufacturer/sponsors:

  • Baxter Healthcare

  • Fresenius Kabi

II Professional/specialist and patient/carer groups:

  • Ambulance Service Association

  • British Association for Immediate Care (BASICS)

  • British Association for Accident and Emergency Medicine

  • British Association of Paramedics

  • British Trauma Society

  • Department of Health

  • Faculty of Pre-hospital Care

  • Joint Royal Colleges Ambulance Liaison Committee

  • Royal College of Anaesthetists

  • Royal College of General Practitioners

  • Royal College of Nursing

  • Royal College of Paediatrics and Child Health

  • Royal College of Physicians

  • Royal College of Surgeons

  • Royal Pharmaceutical Society

  • The Faculty of Accident and Emergency Medicine

  • Welsh Assembly Government

III Commentator organisations (without the right of appeal):

  • NHS-Quality Improvement Scotland

  • NHS Confederation

  • NHS Purchasing and Supply Agency

C The following individuals were selected from clinical expert and patient advocate nominations from the professional/specialist and patient/carer groups. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on prehospital initiation of fluid replacement therapy in trauma by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the Appraisal Consultation Document:

  • Mr Tim Coats, Senior Lecturer in Accident & Emergency/Prehospital Care, Royal College of Surgeons Trauma Committee

  • Dr Tom Clutton-Brock, Consultant Anaesthetist, Royal College of Anaesthetists

  • Mr Mark E Cooke, National Clinical Effectiveness Manager, Ambulance Service Association

  • Mr Henry R Guly, Consultant in Accident and Emergency Medicine, Derriford Hospital, Plymouth

  • Dr Peter A Oakley, Consultant in Anaesthesia and Trauma, University Hospital of North Staffordshire, Stoke-on-Trent, Past President of the British Trauma Society

  • Dr Tina Sajjanhar, Consultant in Paediatric Accident and Emergency, Royal College of Paediatrics and Child Health, Representative on Joint Royal Colleges Ambulance Liaison Committee